Biotechnological approaches to the production of plant-derived promising anticancer agents: An update and overview - 18/11/20
pages | 17 |
Iconographies | 12 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | This review focuses on modern biotechnological approaches to improve the productivity of three major groups of anticancer compounds including aryltetralin lignan, taxol and alkaloids, and their analogs. |
• | This article also provides comprehensive information on biosynthesis, mode of action, elicitation and pharmacokinetics of these anticancer compounds. |
• | Moreover, current studies on the metabolites and their respective enzymes, genes, trans-factors to decipher their transcriptomics, proteomics and metabolomics regulation mechanisms have also been reported in this review. |
Abstract |
The plant kingdom is a rich source of bioactive compounds, many of which have been used since pre-history for their therapeutic properties to treat a range of illnesses. These metabolites have recently attracted attention to their antineoplastic activities to treat various cancers relying on different mechanisms. Some of these molecules are glycosides, which have proven useful as anti-cancer agents, namely podophyllotoxin (PPT) anaryltetralin lignan or alkaloids. There are three primary forms of alkaloids, such as indole alkaloids (vincristine and vinblastine from Catharanthus roseus), quinoline alkaloid (camptothecin from Camptotheca acuminata), and diterpenoid alkaloid (taxol and it's analogous from Taxus and Corylus species). This review considers various plant biotechnology approaches used to enhance the production of these anticancer molecules in different species. In this regard, many in vitro culture techniques such as stimulation of suspension culture and hairy roots are being used to investigate the effects of plant growth regulators and elicitors on various explants.
Le texte complet de cet article est disponible en PDF.Keywords : Podophyllotoxin, Camptothecin, Paclitaxel, Biosynthetic pathways, In vitro culture, Heterologous host, Elicitation
Plan
Vol 132
Article 110918- décembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?